Seelos Therapeutics SEEL

$ 1.28 -47.76%

Quarterly report 2024-Q2
added 08-14-2024

Seelos Therapeutics EV/EBITDA Ratio 2011-2024 | SEEL

Annual EV/EBITDA Ratio Seelos Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-0.622	-5.11	-0.391	0.025	-2.13	-1.52	-2.9	-2	-3.21	-7.1	-5.48

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
0.025	-7.1	-2.77